This is a Validated Antibody Database (VAD) review about rabbit TIMP2, based on 3 published articles (read how Labome selects the articles), using TIMP2 antibody in all methods. It is aimed to help Labome visitors find the most suited TIMP2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TIMP2 synonym: metalloproteinase inhibitor 2; tissue inhibitor of metalloproteinase-2

Invitrogen
mouse monoclonal (3A4)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to study the clinical significance and expression of metalloproteases and their inhibitors in invasive breast carcinoma endothelial cells, Invitrogen TIMP2 antibody (Thermo, MA5-12207) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Clin Breast Cancer (2016) ncbi
mouse monoclonal (3A4)
  • immunohistochemistry - paraffin section; human; fig 2
In order to investigate the roles of MMP-9 and TIMP-2 in regulating tumor progression in ameloblastomas, Invitrogen TIMP2 antibody (Thermo Scientific, 3A4) was used in immunohistochemistry - paraffin section on human samples (fig 2). Appl Immunohistochem Mol Morphol (2016) ncbi
mouse monoclonal (3A4)
  • immunohistochemistry; human; 1:200
Invitrogen TIMP2 antibody (Thermo Fisher Scientific, 3A4) was used in immunohistochemistry on human samples at 1:200. BMC Cancer (2014) ncbi
Articles Reviewed
  1. Cid S, Eiró N, Gonzalez L, Béridze N, Vazquez J, Vizoso F. Expression and Clinical Significance of Metalloproteases and Their Inhibitors by Endothelial Cells From Invasive Breast Carcinomas. Clin Breast Cancer. 2016;16:e83-91 pubmed publisher
  2. Nunia K, Urs A, Kumar P. Interplay Between MMP-9 and TIMP-2 Regulates Ameloblastoma Behavior and Tooth Morphogenesis. Appl Immunohistochem Mol Morphol. 2016;24:364-72 pubmed publisher
  3. Kim G, Lee J, Choi Y, Lee K, Lee J, Nam J, et al. Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer. BMC Cancer. 2014;14:959 pubmed publisher